| Mdm2 promotes the rapid degradation of p53 Y Haupt, R Maya, A Kazaz, M Oren Nature 387 (6630), 296, 1997 | 4358 | 1997 |
| Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 E Yonish-Rouach, D Resnftzky, J Lotem, L Sachs, A Kimchi, M Oren Nature 352 (6333), 345, 1991 | 2479 | 1991 |
| mdm2 expression is induced by wild type p53 activity. Y Barak, T Juven, R Haffner, M Oren The EMBO journal 12 (2), 461-468, 1993 | 1524 | 1993 |
| The first 30 years of p53: growing ever more complex AJ Levine, M Oren Nature Reviews Cancer 9 (10), 749, 2009 | 1403 | 2009 |
| Transcriptional activation of miR-34a contributes to p53-mediated apoptosis N Raver-Shapira, E Marciano, E Meiri, Y Spector, N Rosenfeld, ... Molecular cell 26 (5), 731-743, 2007 | 1352 | 2007 |
| Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. CA Finlay, PW Hinds, TH Tan, D Eliyahu, M Oren, AJ Levine Molecular and cellular biology 8 (2), 531-539, 1988 | 1345 | 1988 |
| Decision making by p53: life, death and cancer M Oren Cell death and differentiation 10 (4), 431, 2003 | 1218 | 2003 |
| p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs M Müller, S Wilder, D Bannasch, D Israeli, K Lehlbach, M Li-Weber, ... Journal of Experimental Medicine 188 (11), 2033-2045, 1998 | 982 | 1998 |
| Participation of p53 cellular tumour antigen in transformation of normal embryonic cells D Eliyahu, A Raz, P Gruss, D Givol, M Oren Nature 312 (5995), 646, 1984 | 888 | 1984 |
| Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 D Michalovitz, O Halevy, M Oren Cell 62 (4), 671-680, 1990 | 881 | 1990 |
| Wild-type p53 can inhibit oncogene-mediated focus formation D Eliyahu, D Michalovitz, S Eliyahu, O Pinhasi-Kimhi, M Oren Proceedings of the National Academy of Sciences 86 (22), 8763-8767, 1989 | 853 | 1989 |
| The p53–Mdm2 module and the ubiquitin system D Michael, M Oren Seminars in cancer biology 13 (1), 49-58, 2003 | 825 | 2003 |
| ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage R Maya, M Balass, ST Kim, D Shkedy, JFM Leal, O Shifman, M Moas, ... Genes & development 15 (9), 1067-1077, 2001 | 785 | 2001 |
| Regulation of the p53 tumor suppressor protein M Oren Journal of Biological Chemistry 274 (51), 36031-36034, 1999 | 697 | 1999 |
| p53 in growth control and neoplasia TM Gottlieb, M Oren Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1287 (2-3), 77-102, 1996 | 672 | 1996 |
| Interaction of c-Abl and p73α and their collaboration to induce apoptosis R Agami, G Blandino, M Oren, Y Shaul Nature 399 (6738), 809, 1999 | 659 | 1999 |
| Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Y Haupt, S Rowan, E Shaulian, KH Vousden, M Oren Genes & development 9 (17), 2170-2183, 1995 | 653 | 1995 |
| Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes L Galluzzi, SA Aaronson, J Abrams, ES Alnemri, DW Andrews, ... Cell death and differentiation 16 (8), 1093, 2009 | 617 | 2009 |
| Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 L Galluzzi, I Vitale, SA Aaronson, JM Abrams, D Adam, P Agostinis, ... Cell Death & Differentiation 25 (3), 486-541, 2018 | 600 | 2018 |
| Localization of gene for human p53 tumour antigen to band 17p13 M Isobe, BS Emanuel, D Givol, M Oren, CM Croce nature 320 (6057), 84-85, 1986 | 597 | 1986 |
